Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02850003 · ClinicalTrials.gov registry record · Phase 1
Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel
A Phase 1 study of Acne, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02850003: Completed Phase 1 study of Acne, sponsored by Bausch Health Americas.
NCT02850003 is a Phase 1 study of Acne that has completed, run by Bausch Health Americas. The registered enrollment target is 20 participants, below the 142-participant average among 26 other Acne trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02850003, a Phase 1 study of Acne, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel.
Primary Outcome
Acne severity will be determined by the investigator/evaluator based on the global assessment of the inflammatory and non-inflammatory lesions of facial acne. Evaluations will be graded on a static scale ranging from 0 (clear) to 4 (severe).
Conditions Studied
Interventions
- DRUG IDP-120 Gel
Study Locations (1)
Texas
- Valeant Site 01 - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
What the finished NCT02850003 record still lists
NCT02850003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 142-participant average among 26 other Acne trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 1 intervention - of which IDP-120 Gel is the first listed.
NCT02850003 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02850003 about?
NCT02850003 is a clinical study titled "Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel". Study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel.
What is the current status of trial NCT02850003?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2016-06. Estimated completion is 2016-11.
What conditions does trial NCT02850003 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT02850003?
The interventions under investigation include: IDP-120 Gel (DRUG).
Who is sponsoring clinical trial NCT02850003?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02850003 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02850003's enrollment target sits among peer trials
20 23rd of 26 higher than 3 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne
RECRUITING · Phase 1
-
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
RECRUITING · Phase 1
-
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
RECRUITING · Phase 1
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia